KCM

Kynam Capital Management Portfolio holdings

AUM $1.34B
1-Year Est. Return 9.24%
This Quarter Est. Return
1 Year Est. Return
+9.24%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.34B
AUM Growth
+$414M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
36
New
Increased
Reduced
Closed

Top Buys

1
+$35M
2
+$20M
3
+$18.3M
4
VERA icon
Vera Therapeutics
VERA
+$17.5M
5
PHVS icon
Pharvaris
PHVS
+$16.8M

Top Sells

1
+$18.2M
2
+$14.1M
3
+$9.19M
4
COGT icon
Cogent Biosciences
COGT
+$8.71M
5
LQDA icon
Liquidia Corp
LQDA
+$2.49M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLDX icon
1
Celldex Therapeutics
CLDX
$1.96B
$158M 11.75%
6,100,729
SNDX icon
2
Syndax Pharmaceuticals
SNDX
$1.77B
$131M 9.76%
8,520,000
VERA icon
3
Vera Therapeutics
VERA
$2.87B
$117M 8.71%
4,027,800
+600,913
COGT icon
4
Cogent Biosciences
COGT
$5.95B
$113M 8.43%
7,886,172
-606,385
PCVX icon
5
Vaxcyte
PCVX
$6.08B
$111M 8.24%
3,071,588
VRDN icon
6
Viridian Therapeutics
VRDN
$3.06B
$95.6M 7.11%
4,427,927
CGON icon
7
CG Oncology
CGON
$3.49B
$80.8M 6.01%
2,005,205
-452,462
BCRX icon
8
BioCryst Pharmaceuticals
BCRX
$1.6B
$71.3M 5.31%
9,390,270
+926,528
BEAM icon
9
Beam Therapeutics
BEAM
$2.75B
$61.1M 4.55%
2,517,647
+100,000
IMCR icon
10
Immunocore
IMCR
$1.96B
$36.7M 2.73%
1,009,267
+33,000
MBX
11
MBX Biosciences
MBX
$1.44B
$35M 2.61%
+2,000,000
ENGN icon
12
enGene Holdings
ENGN
$540M
$34.1M 2.54%
4,994,090
WVE icon
13
Wave Life Sciences
WVE
$1.25B
$33.4M 2.49%
4,560,053
TYRA icon
14
Tyra Biosciences
TYRA
$1.15B
$32.6M 2.43%
2,329,998
TVTX icon
15
Travere Therapeutics
TVTX
$3.13B
$22.7M 1.69%
949,727
-590,964
DVAX icon
16
Dynavax Technologies
DVAX
$1.28B
$21.3M 1.59%
2,145,319
NRIX icon
17
Nurix Therapeutics
NRIX
$1.83B
$20M 1.49%
2,168,605
+995,000
UTHR icon
18
United Therapeutics
UTHR
$21.1B
$20M 1.49%
+67,588
APLS icon
19
Apellis Pharmaceuticals
APLS
$2.99B
$18.3M 1.36%
+808,607
PHVS icon
20
Pharvaris
PHVS
$1.72B
$16.8M 1.25%
+675,000
RLAY icon
21
Relay Therapeutics
RLAY
$1.33B
$15.1M 1.12%
2,887,014
CGEM icon
22
Cullinan Oncology
CGEM
$626M
$13.7M 1.02%
2,302,172
+206,174
CTMX icon
23
CytomX Therapeutics
CTMX
$669M
$11.6M 0.87%
3,646,503
+1,492,090
AMRN
24
Amarin Corp
AMRN
$344M
$9.44M 0.7%
576,111
BNR
25
Burning Rock Biotech
BNR
$215M
$8.61M 0.64%
994,883
1
2